Novabay Pharmaceuticals Inc Revenu
Quel est le Revenu de Novabay Pharmaceuticals Inc?
Le Revenu de Novabay Pharmaceuticals Inc est $12.023M
Quelle est la définition de Revenu?
Le revenu est le revenu qu'une entreprise tire de ses activités commerciales normales, généralement de la vente de biens et de services aux clients.
Revenue is also referred to as sales or turnover. Some companies receive revenue from interest, royalties, or other fees. Revenue may refer to business income in general, or it may refer to the amount, in a monetary unit, earned during a period of time, as in "Last year, Company X had revenue of $42 million". Profits or net income generally imply total revenue minus total expenses in a given period.
In accounting, revenue is often referred to as the "top line" due to its position on the income statement at the very top. This is to be contrasted with the "bottom line" which denotes net income.
Revenu des entreprises dans Health Care secteur sur NYSEMKT par rapport à Novabay Pharmaceuticals Inc
Que fait Novabay Pharmaceuticals Inc?
novabay pharmaceuticals $nby is a biopharmaceutical company focusing, commercializing and developing its non-antibiotic anti-infective products to address the unmet therapeutic needs of the global eye care market. novabay has two distinct product categories: the neutrox™ family of products, led by avenova™ for the eye care market, neutrophase® for wound care, and cellerx™ for the dermatology market; and aganocide® compounds, led by auriclosene™. novabay is commercializing avenova, a prescription lid and lash hygiene product for the management of the chronic eye conditions of blepharitis and meibomian gland dysfunction – also known as dry eye syndrome. these difficult-to-manage conditions affect approximately 30 million americans, with an annual market potential that novabay estimates at $500 million. novabay is gaining market traction with avenova through its 35-medical direct sales representatives under veteran leadership. avenova is available for order in 90% of all pharmacies across
Entreprises avec revenu similaire à Novabay Pharmaceuticals Inc
- IDEAYA Biosciences a Revenu de $11.960M
- Earth Science Tech a Revenu de $11.960M
- Far East International a Revenu de HKD$11.980M
- Golden Minerals a Revenu de $12.000M
- Checkit plc a Revenu de £12.000M
- aap Implantate AG a Revenu de €12.004M
- Novabay Pharmaceuticals Inc a Revenu de $12.023M
- California Software a Revenu de ₨12.050M
- PyroGenesis Canada a Revenu de CAD$12.063M
- Biotricity a Revenu de $12.063M
- Otrs Ag a Revenu de €12.129M
- Jupiter US Smaller Cos. Plc a Revenu de £12.140M
- The Limestone Boat a Revenu de CAD$12.140M